FDAnews
www.fdanews.com/articles/145808-combination-of-gilead-bristol-myers-hepatitis-c-drugs-show-promise-in-study

Combination of Gilead, Bristol-Myers Hepatitis C Drugs Show Promise in Study

April 20, 2012
A regimen combining experimental drugs from Gilead Sciences and Bristol-Myers Squibb suppressed the hepatitis C virus in most patients four weeks after completing treatment, according to a new study.
The Wall Street Journal